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Abstract
Background: Maximal oxygen uptake (VO2max) predicts mortality and is associated with endurance performance. Trained
subjects have a high VO2max due to a high cardiac output and high metabolic capacity of skeletal muscles. Peroxisome
proliferator-activated receptor c coactivator 1a (PGC-1a), a nuclear receptor coactivator, promotes mitochondrial
biogenesis, a fiber-type switch to oxidative fibers, and angiogenesis in skeletal muscle. Because exercise training increases
PGC-1a in skeletal muscle, PGC-1a-mediated changes may contribute to the improvement of exercise capacity and VO2max.
There are three isoforms of PGC-1a mRNA. PGC-1a-b protein, whose amino terminus is different from PGC-1a-a protein, is a
predominant PGC-1a isoform in response to exercise. We investigated whether alterations of skeletal muscle metabolism by
overexpression of PGC-1a-b in skeletal muscle, but not heart, would increase VO2max and exercise capacity.
Methodology/Principal Findings: Transgenic mice showed overexpression of PGC-1a-b protein in skeletal muscle but not
in heart. Overexpression of PGC-1a-b promoted mitochondrial biogenesis 4-fold, increased the expression of fatty acid
transporters, enhanced angiogenesis in skeletal muscle 1.4 to 2.7-fold, and promoted exercise capacity (expressed by
maximum speed) by 35% and peak oxygen uptake by 20%. Across a broad range of either the absolute exercise intensity, or
the same relative exercise intensities, lipid oxidation was always higher in the transgenic mice than wild-type littermates,
suggesting that lipid is the predominant fuel source for exercise in the transgenic mice. However, muscle glycogen usage
during exercise was absent in the transgenic mice.
Conclusions/Significance: Increased mitochondrial biogenesis, capillaries, and fatty acid transporters in skeletal muscles
may contribute to improved exercise capacity via an increase in fatty acid utilization. Increases in PGC-1a-b protein or
function might be a useful strategy for sedentary subjects to perform exercise efficiently, which would lead to prevention of
life-style related diseases and increased lifespan.
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Introduction
Cardiorespiratory fitness (CRF) is a strong and independent
predictor of all-cause and cardiovascular disease mortality [1,2]. A
recent meta-analysis showed that compared to participants with
high CRF, those with low CRF had a relative risk for all-cause
mortality of 1.70 (95% CI, 1.51–1.92; P,0.001) and for coronary
heart disease (CHD)/cardiovascular disease (CVD) events of 1.56
(95% CI, 1.39–1.75; P,0.001) [3]. Maximal O2 uptake (VO2max),
the maximal amount of O2 per unit of time, is considered the gold
standard measure of CRF. Central O2 delivery from the heart and
peripheral use of O2 in skeletal muscle contribute to training-
induced changes in VO2max, although the genetic contribution of
VO2max was estimated at 47% [4,5]. The pump capacity of the
heart is considered to be a primary determinant of VO2max in
humans [6]. On the other hand, in subjects receiving a different
intensity of exercise, muscle citrate synthase (CS) activity, a
determinant of mitochondrial number (or volume), was closely
correlated to VO2max [7,8]. More recently, aerobic interval
training was shown to improve not only maximal stroke volume
(measured as peak O2 pulse) but also Ca
2+ cycling and
mitochondrial capacity in skeletal muscle (assessed by improved
sarcoplasmic reticulum ATPase capacity and peroxisome prolif-
erator-activated receptor c coactivator 1a (PGC-1a) levels in
skeletal muscle) to a larger extent than continuous moderate
exercise in heart failure and metabolic syndrome patients [9,10].
However, it is not clear whether increased mitochondrial capacity,
fatty acid oxidation and blood flow in skeletal muscle in response
to exercise training contribute to an increase in VO2max.
PGC-1a is induced by exercise and promotes mitochondrial
biogenesis, a fiber-type switch to oxidative fibers, and angiogenesis
in skeletal muscle [11,12]. There are three isoforms of PGC-1a
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PGC-1a-c are transcribed from an alternate exon, 1b. PGC-1a-a
encodes a protein of 795 amino acids [12–14]. All of these
promote mitochondrial biogenesis and angiogenesis in skeletal
muscles. However, sixteen amino acids at the amino terminus in
PGC-1a-a differ from PGC-1a-b and PGC-1a-c, and this small
difference may affect the binding to putative transcription factors,
possibly leading to different metabolic responses. We previously
reported that exercise-induced expression of isoforms of PGC-1a
mRNA was dependent on the intensity of exercise [15]. A single
bout of low-intensity exercise could increase PGC-1a-b and PGC-
1a-c mRNAs via b2-adrenergic receptor (AR) activation, whereas
an increase in PGC-1a-a mRNA expression required high-
intensity exercise and was independent of b2-AR activation.
Among the PGC-1a isoforms, the increase in PGC-1a-b
expression was the largest in response to bouts of exercise [15].
Calvo et al. addressed the effects of increased muscle PGC-1a-a
levels on exercise performance [16]. Mice with muscle-specific
overexpression of PGC-1a-a (MCK-PGC-1a-a) demonstrated an
improvement in exercise performance and also exhibited ,20%
higher peak oxygen uptake than wild-type mice. However, the
MCK-PGC-1a-a mice did have elevated PGC-1a-a mRNA levels
in the heart, and it may thus be speculated that this was sufficient
to elicit the observed effects on peak oxygen uptake.
The generation of transgenic mice overexpressing PGC-1a-b in
skeletal muscle but not in the heart may help to elucidate the role
of PGC-1a in the improvement of exercise performance and
increases in VO2max. To clarify this, we analyzed transgenic mice
that overexpressed PGC-1a-b, the most exercise-inducible iso-
form, in skeletal muscle.
Methods
Transgenic mice
The methods for the generation of transgenic mice overex-
pressing PGC-1a-b in skeletal muscle were described previously
[13]. The human a-skeletal actin promoter provided by Drs. E. C.
Hardeman and K. L. Guven (Children’s Medical Research
Institute, Australia) was used to express PGC-1a-b in skeletal
muscle. The transgenic mice (heterozygotes, BDF 1 background)
and wild-type C57BL6 mice were crossed and the offspring
(heterozygote and wild-type, born at the same period) were used
for the experiments. Mice were cared for in accordance with the
NIH Guide for the Care and Use of Laboratory Animals and our
institutional guidelines. All animal experiments were conducted
with the approval of the National Institute of Health and Nutrition
Ethics Committee on Animal Research (approval ID: No 908,
1008, and 1111).
Body Composition Analysis
Mice were scanned with a Lunar PIXI mus2 densitometer
(Lunar Corporation, Madison, WI), equipped for dual energy X-
ray absorptiometry (DEXA) [17].
Quantitative Real-time RT-PCR
RNA preparation methods and quantitative real-time RT-PCR
were performed as described previously [13]. The mouse-specific
primer pairs used were as shown in Table 1.
Western blot
Frozen skeletal muscle and heart was powdered under liquid
nitrogen, and then homogenized in RIPA Lysis Buffer (Upstate
Bitechnology, Lake Placid, NY) containing 1 mM sodium
orthovanadate, 1 mM sodium fluoride, and the ‘‘Complete Mini,
EDTA-free’’ protease inhibitor cocktail (1 tablet per 10 ml). After
three cycles of freezing and thawing, the supernatant was
separated by centrifugation at 20,400 g for 15 min at 4uC. Fifteen
mg of protein from the supernatant was applied onto an SDS-
PAGE gel. PGC-1a protein was identified by Western blotting
with anti-PGC-1a (Rabbit polyclonal IgG) against the carboxyl
terminus, 777–797 (Calbiochem, San Diego, CA).
Measurement of mitochondrial DNA copy number and
CS activity
The mitochondrial DNA copy number was normalized to the
copy number of a gene contained in the nuclear genome. The
mitochondrial DNA copy number in PGC-1a-b transgenic mice
was expressed as a percentage of the copy number in control wild-
type mice. Real-time PCR was used to estimate the copy number
of specific genes in skeletal muscles as described previously [18].
CS activity was measured as described previously [19].
Preparation of the mitochondrial fraction from skeletal
muscle
To obtain a pure and intact mitochondrial fraction, differential
centrifugation was used [20–22]. All procedures were performed
at 0–4uC. Media used were as follows: medium I: 100 mM KCl,
5 mM MgSO4?7H2O, 5 mM EDTA, and 50 mM Tris?HCl,
pH 7.4; medium II: medium I plus 1 mM ATP, pH 7.4; medium
III: 220 mM sucrose, 70 mM mannitol, 10 mM Tris?HCl, and
1 mM EDTA, pH 7.4. Fresh skeletal muscle was immediately
placed in ice-cold medium I and then blotted and weighed. Muscle
was minced with scissors in 1 ml of medium II. Minced muscle
was homogenized in 20 vol of ice-cold medium II using a Teflon
pestle. The homogenate was treated with a protease (Sigma
P5380, 0.025 ml/g tissue) for 5 min to digest the myofibrils.
Addition of 10 ml of ice-cold medium II was used to diminish the
action of the protease. Samples were spun at 5,000 g for 5 min,
and the supernatant was removed. The pellet was resuspended in
10 vol of medium II and spun at 800 g for 10 min. The
mitochondria found in the supernatant were spun at 12,000 g for
10 min. The pellet was washed in medium II and spun at 12,000 g
for 10 min at 4uC. The pellet was resuspended in 1 ml medium
III/mg tissue.
Measurement of mitochondrial respiration
Mitochondrial oxygen consumption was measured polaro-
graphically using an Oxygraph oxygen electrode unit (Hansatech
Instruments, Kings Lynn, UK) at 30uC. The respiration was
measured in a medium containing 225 mM mannitol, 75 mM
sucrose, 10 mM KCl, 10 mM Tris-HCl, and 5 mM KH2PO4,
pH 7.2 [23]. For the measurement of pyruvate and malate
oxidation, the following substrate combinations were used: 5 mM
pyruvate+5 mM malate+1 mM ATP. Oxidative phosphorylation
(state III respiration) was initiated by adding 125 nmol ADP in the
presence or absence of 5 mg/ml oligomycin.
Histological Analyses
Samples of the tibialis anterior (TA) muscle at 10 weeks of age
were frozen in liquid nitrogen-cooled isopentane. The identifica-
tion of capillaries was performed using the anti-CD31 antibody
(#553370, BD-Pharmingen, Franklin Lakes, NJ, USA), which
recognizes platelet endothelial cell adhesion molecule-1(PECAM),
a transmembranous glycoprotein strongly expressed by vascular
endothelial cells [24,25]. The acetone fixed slides were incubated
for 1 h with anti-CD31 antibody and for 30 min with Simple Stain
Mouse MAX PO (rat) (Nichirei, Tokyo, Japan). Visualization of
PGC-1a-b Increases Exercise Performance
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28290antibody staining was achieved using 3,39-diaminobenzidine
tetrahydrochloride as the chromogen. Capillary density (num-
ber/mm
2) and the capillary-to-fiber ratio were measured directly
from images of micrographs projected on a screen.
Measurement of spontaneous physical activity
To examine spontaneous physical activity, mice were housed in
cages equipped with an infrared sensor, the activity was measured
for 24 h, and the data were analyzed using a Supermex system
(Muromachi Kikai, Tokyo, Japan).
Measurement of exercise capacity
Exercise capacity was determined by an exercise tolerance test
during the peak oxygen uptake challenge as described previously
[16] with modifications (no incline in our protocols). To determine
peak VO2, mice were placed in an air-tight treadmill (Muromachi
Kikai) for 60 min at 0 m/min. The mice were then challenged at
10 m/min. The speed increased 2 m/min every 3 min until
exhaustion. The mice ran until exhaustion, which is defined as
remaining on the shocker plate for more than 10–15 s, as
described previously [16]. Please make a note that the definition of
exhaustion was not the same as used in other studies, in which
volitional fatigue was taking into consideration [26,27].
Measurement of oxygen consumption and carbon
dioxide production
Open-circuit indirect calorimetry was performed with an O2/
CO2 metabolism measuring system for small animals (MK-
5000RQ; Muromachi Kikai). The system monitored VO2 and
VCO2 at 3-min intervals and calculated the respiratory quotient
Table 1. Mouse-specific primer pairs used for quantitative RT-PCR.
Forward Reverse
36B4 59-GGCCCTGCACTCTCGCTTTC-39 59-TGCCAGGACGCGCTTGT-39
PGC-1a 59-CGGAAATCATATCCAACCAG-39 59-TGAGGACCGCTAGCAAGTTTG-39
COX2 59-CCGACTAAATCAAGCAACAGTAACA-39 59-AAATTTCAGAGCATTGGCCATAG-39
COX4 59-CTATGTGTATGGCCCCATCC-39 59-AGCGGGCTCTCACTTCTTC-39
MHC1 59-CCAAGGGCCTGAATGAGGAG-39 59-GCAAAGGCTCCAGGTCTGAG-39
MHC2A 59-AAGCGAAGAGTAAGGCTGTC-39 59-GTGATTGCTTGCAAAGGAAC-39
MHC2X 59-AGGCCAGGGTCCGTGAA-39 59-CCACGTTGCGCTTCTGTTC-39
MHC2B 59-ACAAGCTGCGGGTGAAGAGC-39 59-CAGGACAGTGACAAAGAACG-39
GYS1 59-CCCCCAACTCCGGAACTG-39 59-AATACACCTTACAACCCTTGCTGTT-39
PHKA1 59-AGCGTTCGTCCCACTGATTC-39 59-GCTCCAACAGCACCAATCTCA-39
PYGM 59-GCATCAAAAGGGAGCCCAAT-39 59-GCCTTGCCTCCAATCATGA-39
GLUT4 59-ATGGCTGTCGCTGGTTTCTC-39 59-ACCCATGCCGACAATGAAGT-39
HK2 59-GGAACCCAGCTGTTTGACCA-39 59-CAGGGGAACGAGAAGGTGAAA-39
PFKM 59-GCCATCGCCGTGTTGAC-39 59-GCCCTGACGGCAGCATT-39
PFKFB3 59-ACGAAGATGCCGTTGGAACT-39 59-TCGACGGGCACCCAGAT-39
PKM2 59-TTGACTCTGCCCCCATCAC-39 59-GCAGGCCCAATGGTACAAAT-39
PDK4 59-AGCTGGTGAAGAGCTGGTATATCC-39 59-TCTGGTCTTCTGGGCTCTTCTC-39
LPL 59-CCATGGATGGACGGTAACG-39 59-TACAGGGCGGCCACAAGT-39
CD36 59-CGGAACTGTGGGCTCATTG-39 59-GCATGAGAATGCCTCCAAACA-39
FATP1 59-TGACAGTGCCACCAACAAGAA-39 59-GCGCTATCGCCCTTTCG-39
FABP-pm 59-CGAGCAGGGCATCAATGTCT-39 59-CCGTACAGGCCCATGTTCTT-39
FABP3 59-ACTCGGTGTGGGCTTTGC-39 59-ATGATGGTAGTAGGCTTGGTCATG-39
CPT1 59-GTGCAAGCAGCCCGTCTAG-39 59-TTGCGGCGATACATGATCAT-39
MCAD 59-TGGATCTGTGCAGCGGATT-39 59-GGGTCACCATAGAGCTGAAGACA-39
Mb 59-GGCAGCTGGTGCTGAATGT-39 59-TAAACAGACCGATGAGGACTTCCT-39
VEGF-A 59-CGAGATAGAGTACATCTTCAAGCC-39 59-TCATCGTTACAGCAGCCTGC-39
VEGF-B 59-AAAAAAAAAGGAGAGTGCTGTGAAG-39 59-TCCCAGCCCGGAACAGA-39
PDGF-B 59-GGTCAGCGCCGAGGG-39 59-GCGGATGGAGTGGTCGC-39
nNOS 59-AAGGAGCAAGGAGGCCATAT-39 59-ATATGTTCTGAGGGTGACCCC-39
eNOS 59-AAGGAAGTAGCCAATGCAGTGAA-39 59-TCACACGCTTCGCCATCA-39
Nur77 59-GGGTGACCCCACTATTTGTC-39 59-CGGAAGAGATCTCGAGTTGG-39
PGC, peroxisome proliferator-activated receptor c coactivator; COX, cytochrome c oxidase; MHC, myosin heavy chain; GYS, glycogen synthase; PHKA, phosphorylase
kinase alpha, PYGM, muscle glycogen phosphorylase; GLUT, glucose transporter; HK, hexokinase; PFKM, muscle phosphofructokinase; PFKFB, 6-phosphofructo-2-kinase/
fructose-2,6-biphosphatase; PKM, muscle pyruvate kinase; PDK, pyruvate dehydrogenase kinase; LPL, lipoprotein lipase; FATP, fatty acid transport protein; FABP-pm,
plasma membrane fatty acid binding protein; FABP, fatty acid binding protein; CPT, carnitine palmitoyltransferase; MCAD, medium chain acyl-CoA dehydrogenase; Mb,
myoglobin; VEGF, vascular endothelial growth factor; PDGF, platelet-derived growth factor; nNOS, neuronal nitric oxide synthase; eNOS, endothelial nitric oxide
synthase.
doi:10.1371/journal.pone.0028290.t001
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the dark (from 19:00 to 7:00) or light (from 7:00 to 16:30) period
under fasting conditions.
For measurement of VO2 and VCO2 during exercise, mice
were allowed to acclimatize to the air-tight treadmill chamber
(Muromachi Kikai) for 30 min, at which point VO2 and VCO2
were stable. Measurements were continued for another 30 min
while mice were maintained in a sedentary state. Mice were then
exercised as described above.
The substrate utilization rate and energy production rate were
calculated using the formula used by Ferrannini where the rate of
glucose oxidation (g/min)=4.55VCO2 (l/min)-3.21VO2 (l/min)-
2.87N(mg/min), the rate of lipid oxidation (g/min)=1.67 (VO2-
VCO2)-1.92N, and the rate of energy production (kcal/
min)=3.91 VO2+1.10VCO2-3.34N, and where N is the rate of
urinary nitrogen excretion used to estimate protein oxidation [28].
However, considering that only a small portion of resting and
exercise energy expenditure arises from protein oxidation, the
contributions of protein oxidation were ignored [29].
Other assays
Glycogen content in the gastrocnemius and liver was measured
as glycosyl units after acid hydrolysis [30]. Blood glucose
concentration was measured with a glucose analyzer (Glucometer
DEX; Bayer Medical, Tokyo, Japan). Lactate levels were
measured by Lactate Pro (Arkray, Kyoto, Japan). Blood samples
were obtained by cutting the tail tip.
Statistical analysis
Data were analyzed by one-way ANOVA. Where differences
were significant, each group was compared with the other by
Student’s t test (JMP 5.1.2; SAS, Campus Drive, Cary, NC, USA).
In the exercise tolerance test, a Kaplan-Meier survival curve was
obtained, and a comparison of groups was performed using the
log-rank test (StatView 5.0). Statistical significance was defined as
P,0.05. Values are shown as mean 6 SE.
Results
Skeletal muscle-specific expression of PGC-1a-b increases
the biogenesis of mitochondria in skeletal muscles but
not in heart
Skeletal muscle specific PGC-1a-b mice were made with a DNA
construct containing the 59-flanking skeletal muscle-specific
regulatory region and the promoter of the human a-skeletal actin
gene, and a cDNA encoding a PGC-1a-b [13]. Quantitative real-
time RT-PCR showed that PGC-1a mRNA was expressed 29.2-
and 26.8-fold higher in skeletal muscles of transgenic lines A and
B, respectively, than in wild-type mice, but there was no difference
in heart muscle (Fig. 1A).
PGC-1a protein was identified by Western blot analysis with an
antibody against the carboxyl terminus of the PGC-1a-a protein,
because the carboxyl terminus is the same in all PGC-1a isoforms
(the amino terminus of PGC-1a-b protein differs from PGC-1a-a
protein) [13]. In previous studies on mouse skeletal muscle and
Figure 1. Skeletal muscle-specific expression of PGC-1a-b. (A) Total expression of PGC-1a and its target genes, COX2 and COX4, in wild-type
(Wt) and PGC-1a-b mice (A line and B line) at 25 weeks of age (n=3) was measured by quantitative real-time RT-PCR in skeletal muscle
(gastrocnemius, Gas) and heart. Values are means 6 SE. ***P,0.001 vs. Wt. (B) Total lysates from skeletal muscle (Gas) and heart were subjected to
SDS-PAGE followed by Western blot analysis with anti-PGC-1a antibodies (n=3). Typical blots are shown. For skeletal muscle samples, densitometric
analysis was performed on the bands with increased intensity (arrow heads) following skeletal muscle-specific overexpression of PGC-1a-b.
doi:10.1371/journal.pone.0028290.g001
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considered the full length PGC-1a-a protein [31,32]. In skeletal
muscle taken from the transgenic mice in this study, increased
labeling of the bands at 110 kDa (16.6-fold in line A and 24.8-fold
in line B), 85 kDa (4.5-fold in line A and 5.5-fold in line B) and
45 kDa (5.8-fold in line A and 10.9-fold in line B) were detected
with this antibody (Fig. 1B). In the transgenic mice, a decrease in
the 40 kDa band was also observed. This might be due to the
effects of alternate splicing of endogenous PGC-1a, as suggested in
a previous study [32]. In heart, no significant change was observed
between the genotypes, which confirmed that PGC-1a-b protein
was not over-expressed in these transgenic mice. The increase in
the reaction of several other proteins to this antibody might be due
to post-translational processes of PGC-1a [33], its degradation
products, or non-specific binding to unrelated proteins, although
the precise nature of this is unknown.
In the transgenic mice, the expression of the PGC-1a target
genes, COX2 and COX4, was also elevated in skeletal muscle but
not in heart (Fig. 1A), confirming that expression of PGC-1a-b is
specific to skeletal muscles.
Body weight, body composition and tissue weight were
measured in male transgenic mice at 10 weeks of age. The body
weight, lean body weight, fat weight, and fat% were not different
between PGC-1a-b transgenic mice and wild-type littermates
(Table 2). In PGC-1a-b transgenic mice, the weights of
gastrocnemius, quadriceps, TA and extensor digitorum longus
(EDL) were significantly lower than in wild-type littermates,
however, this difference was not observed in the soleus.
The expression of mRNA in skeletal muscles of genes related to
muscle fiber type and metabolism was determined by quantitative
real-time RT-PCR (Fig. 2). Expression of myosin heavy chain
(MHC) 1 (slow-twitch oxidative fibers, rich in mitochondria) and
2A (fast-twitch oxidative fibers) in quadriceps was increased only in
PGC-1a-b transgenic mice (line B), but the increase in MHC1 was
not significantly different. Compared to wild-type littermates,
expression of MHC 2B (fast-twitch glycolytic fibers) was decreased
to 37% in line A and 13% in line B, and the expression of MHC
2X (mouse fast-twitch oxidative fibers) was increased to 426% in
line A and 462% in line B PGC-1a-b transgenic mice. These data
suggested that expression of oxidative fibers was increased and
glycolytic fibers was decreased in PGC-1a-b transgenic mice,
similar to MCK-PGC-1a-a transgenic mice [34]. The expression
of genes involved in glycogenolysis, such as phosphorylase kinase
alpha (PHKA) 1 and muscle glycogen phsphorylase (PYGM), were
significantly decreased to 20–30% of wild-type in both lines of
transgenic mice. Glucose transporter (GLUT) 4 was decreased to
75% in both lines of transgenic mice. The key enzymes for
glycolysis, such as muscle phosphofructokinase (PFKM), 6-
phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB) 3,
and muscle pyruvate kinase (PKM) 2, were decreased significantly
in the transgenic mice (the decrease of PFKM mRNA in line A
transgenic mice was not significant), suggesting production of
pyruvate was decreased in skeletal muscle that overexpressed
PGC-1a-b. Pyruvate dehydrogenase kinase (PDK) 4 expression
was increased only in line A transgenic mice. On the other hand,
the expression of genes encoding proteins involved in fatty acid
transport and fatty acid oxidation, such as lipoprotein lipase (LPL),
CD36, fatty acid transport protein (FATP) 1, plasma membrane
fatty acid binding protein (FABP-pm), fatty acid binding protein
(FABP) 3, carnitine palmitoyltransferase (CPT) 1 and medium
chain acyl-CoA dehydrogenase (MCAD), was higher in the
transgenic mice. Myoglobin (Mb) and vascular endothelial growth
factors (VEGFs) were also increased in the transgenic mice.
Because VEGF-B might increase endothelial lipid uptake via
stimulation of fatty acid transporter expression in endothelial cells
[35], the increase in VEGF-B and fatty acid transporters in skeletal
muscle overexpressing PGC-1a-b could enhance the rate of fatty
acid transport from the blood stream into skeletal muscle.
Neuronal nitric oxide synthase (nNOS) was decreased in the
transgenic mice. Endothelial NOS (eNOS) was increased in the
skeletal muscle overexpressing PGC-1a-b, suggesting that the
numbers of endothelial cells derived from capillaries in the skeletal
muscle tissue was increased. One of the NR4A orphan nuclear
receptor proteins, Nur77, which regulates expression of genes
linked to glucose metabolism [36], was significantly decreased in
the transgenic mice.
Mitochondrial number or volume in skeletal muscles
increases, but the respiratory functions of mitochondria
per se are normal in transgenic mice
To estimate the numbers of mitochondria in the skeletal muscle
from PGC-1a-b transgenic mice, the mitochondrial encoded-DNA
(COX2) copy number relative to nuclear encoded-DNA (COX4)
copy number and the CS activity were measured. The ratio of
COX2 copy number to COX4 copy number in PGC-1a-b
transgenic mice was higher than in wild-type mice (TA, 2.1-fold in
line A and 2.4-fold in line B; EDL, 2.3-fold in line A and B; soleus,
1.4-fold in line A and B) (Fig. 3A). CS activity in the gastrocnemius
(mixture of red and white fibers) and EDL (white fibers) of PGC-
1a-b transgenic mice was increased 3.7- and 3.8-fold in line A and
4.0- and 3.8-fold in line B, respectively, relative to wild-type mice.
Because CS activity of the soleus (red fibers) was 1.7-fold higher
than those of the gastrocnemius and EDL in the wild-type, the
activity in the soleus of PGC-1a-b transgenic mice was increased
only 1.7-fold in line A and 1.6-fold in line B relative to wild-type
mice. These data suggested that over-expression of PGC-1a-b in
skeletal muscle increased the biogenesis of mitochondria and that
this increase was larger in white glycolytic muscle than red
oxidative muscle.
To study the function of the skeletal muscle mitochondria
themselves, we compared the respiration rates (=oxygen con-
sumption) in isolated mitochondria from gastrocnemius, quadri-
ceps, and TA of PGC-1a-b transgenic mice with those in wild-type
Table 2. Body composition of male wild-type (Wt) and PGC-
1a-b transgenic mice.
Wt PGC-1a-b
A-line B-line
Body weight (g) 22.7660.70 22.4260.61 21.4160.57
Lean (g) 18.6160.43 18.3360.41 18.8760.54
Fat (g) 3.8260.15 3.5760.15 3.5360.25
Fat (%) 17.0760.44 16.3360.38 15.7360.88
Gas (g) 0.24560.009 0.20960.008** 0.21060.006**
Qua (g) 0.29460.012 0.24060.009** 0.25460.008*
TA (g) 0.08560.003 0.08860.004 0.07760.002*
EDL (g) 0.01860.001 0.01660.000* 0.01660.001*
Sol (g) 0.01760.001 0.01960.001 0.01760.001
Values are means 6 SE (n=6–9 at 10 weeks of age).
*P,0.05,
**P,0.01 vs. Wt.
Gas, gastrocnemius; Qua, quadriceps; TA tibialis anterior; EDL, extensor
digitorum longus; Sol, soleus.
doi:10.1371/journal.pone.0028290.t002
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same respiration rate as wild-type on a protein basis of a
mitochondria-rich fraction under conditions where the mitochon-
drial substrate and ADP were not limiting (Fig. 3B), which
mimicked state III respiration [37]. To measure uncoupled
respiration, oligomycin, an inhibitor of the F1F0-ATP synthase,
was added to inhibit oxidative phosphorylation prior to measure-
ment of respiration rates. Oligomycin-insensitive respiration
(=uncoupling) constituted about 20% of the total respiration in
wild-type and PGC-1a-b transgenic mice. CS activity in the
isolated mitochondrial fraction was not different between wild-
type and PGC-1a-b transgenic mice.
These data suggested that the number of mitochondria was
increased in skeletal muscle from PGC-1a-b transgenic mice and
that the mitochondrial oxidative phosphorylation was the same as
in wild-type.
Increased capillary number in transgenic mice
Exercise promotes angiogenesis [38–42]. PGC-1a-b might be a
candidate for inducing angiogenic processes because transfection
of PGC-1a-b into differentiated primary skeletal myocytes isolated
from mice increased VEGF and PDGF-B mRNA expression [12].
This causal relationship was also observed in vivo. Overexpression
of PGC-1a-b in skeletal muscle increased VEGF-A mRNA
expression (Fig. 2). Furthermore, immunohistochemical analysis
of TA muscle was performed to investigate whether PGC-1a-b
induces angiogenesis in vivo (Fig. 4). Each section was analyzed in
superficial and deep regions, and 209–774 and 476–1670 of CD31
positive capillaries were identified in each photograph of the
superficial and deep regions, respectively. The capillary-to-fiber
ratio was increased 2.4–2.6 and 1.3–1.4 fold in the superficial and
deep regions of PGC-1a-b transgenic mice, respectively. Because
the superficial region in TA muscle from wild-type mice was rich
Figure 2. PGC-1a-b induced changes in gene expression in skeletal muscle. Results of quantitative RT-PCR analysis of transcripts encoding
proteins involved in fiber type, glucose metabolism, lipid metabolism, and others in quadriceps from wild-type (Wt) and PGC-1a-b mice (A line and B
line) at 8 weeks of age. Values are means 6 SE (n=6–9). * P,0.05, **P,0.01, *** P,0.001 vs. Wt. MHC, myosin heavy chain; GYS, glycogen synthase;
PHKA, phosphorylase kinase alpha, PYGM, muscle glycogen phosphorylase; GLUT, glucose transporter; HK, hexokinase; PFKM, muscle
phosphofructokinase; PFKFB, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; PKM, muscle pyruvate kinase; PDK, pyruvate dehydrogenase
kinase; LPL, lipoprotein lipase; FATP, fatty acid transport protein; FABP-pm, plasma membrane fatty acid binding protein; FABP, fatty acid binding
protein; CPT, carnitine palmitoyltransferase; MCAD, medium chain acyl-CoA dehydrogenase; Mb, myoglobin; VEGF, vascular endothelial growth
factor; PDGF, platelet-derived growth factor; nNOS, neuronal nitric oxide synthase; eNOS, endothelial nitric oxide synthase.
doi:10.1371/journal.pone.0028290.g002
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suggested that PGC-1a-b-induced angiogenesis in vivo occurred
especially in regions where white glycolytic fibers changed to red
oxidative fibers.
Substrate utilization is not altered in the sedentary and
fasting state in transgenic mice
Increases in mitochondria and capillary numbers in skeletal
muscles in transgenic mice may alter substrate utilization. To
examine this possibility, 8 week-old males of both sedentary PGC-
1a-b transgenic mice and wild-type littermates were subjected to
fasting and their oxygen consumption measured and RQ ratio
calculated. The oxygen consumption and RQ ratio for PGC-1a-b
transgenic and wild-type mice did not differ during the dark cycle
(feeding period) or light cycle (sleeping period) (Table 3). Daily
activity levels were not different between PGC-1a-b transgenic
mice and wild-type littermates. Body weight was similarly reduced
in the two groups after 24-hours of fasting (if energy expenditure
was enhanced, fasting-induced weight reduction increased),
suggesting that over-expression of PGC-1a-b in skeletal muscles
did not affect fatty acid oxidation during fasting.
These data suggested that increases in mitochondria and
capillaries in skeletal muscles did not affect substrate utilization
in the sedentary state.
Exercise capacity of PGC-1a-b transgenic mice and wild-
type littermates
The ability of PGC-1a-b transgenic mice to tolerate a bout of
exercise might be altered. To examine this possibility, mice were
started off running on a treadmill at 10 m/min, and then the
speed was increased by 2 m/min every 3 min until exhaustion
(Fig. 5A). PGC-1a-b transgenic mice could run for a significantly
longer duration with higher exercise-intensity than wild-type
littermates (P=0.002), although the weights of gastrocnemius,
Figure 3. Mitochondrial volume and its function in skeletal muscles overexpressing PGC-1a-b. (A) For estimation of mitochondrial DNA
copy number in skeletal muscle (tibialis anterior (TA), extensor digitorum longus (EDL), and soleus (Sol)), the relative mitochondrial DNA copy number
from individual mice in each group was calculated as the ratio of COX2 (mitochondrial) to COX4 (nuclear) genes as determined by real-time PCR. The
relative mitochondrial DNA copy number was expressed as the percentage of the ratio in wild-type (Wt). CS activity (gastrocnemius (Gas), EDL, and
Sol) was normalized to tissue weight. Values are means 6 SE of Wt and PGC-1a-b transgenic mice (A-line and B-line) at 10 weeks of age (n=3–4).
*P,0.05, ***P,0.001 vs. Wt. {{{P,0.001 vs. Gas. (B) State III respiration rate of the mitochondrial fraction prepared from skeletal muscle (Gas,
quadriceps, and TA) was measured in the presence and absence of 2.5 mg/ml oligomycin. CS activity was also measured in the mitochondrial fraction.
Each data point is the mean value of the measurements normalized to the protein content of the fraction. Skeletal muscles were sampled from both
Wt and PGC-1a-b transgenic mice (A-line and B-line) at 10 weeks of age. Oxidative phosphorylation of the mitochondrial fraction prepared from
skeletal muscle was unchanged in mice overexpressing PGC-1a-b in skeletal muscle.
doi:10.1371/journal.pone.0028290.g003
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type littermates (Table 2). Wild-type littermates ran for a duration
of 47 min at a maximum speed of 40 m/min (total distance was
1.2 km), whereas PGC-1a-b transgenic mice ran for a duration of
64 and 66 min at a maximum speed of 54 and 56 m/min in lines
A and B (total distances were 2.2 or 2.4 km), respectively (Fig. 5A).
To investigate the fuel utilization during exercise and the peak
oxygen consumption, VO2 and VCO2 were monitored simulta-
neously until mice were exhausted. VO2 and VCO2 were
increased gradually as speed increased until exhaustion in every
group of mice (data not shown). In wild-type mice, the RQ ratio
during exercise, which indicated fuel utilization, was increased as
the treadmill speed increase, suggesting that glucose oxidation
became predominant with increasing exercise intensity (Fig. 5B).
However, in both lines of PGC-1a-b transgenic mice, an increase
in the RQ ratio and glucose oxidation with increasing treadmill
speed was not observed. The calculated level of lipid oxidation
during exercise was always higher in PGC-1a-b transgenic mice
than wild-type mice, suggesting that lipid oxidation was the
predominant fuel source for exercise in the transgenic mice. Both
lines of transgenic mice demonstrated a 20% increase in their peak
oxygen uptake compared to wild-type mice (Fig. 5C).
Because of the difference in maximum running speed between
wild-type and transgenic mice, it is possible that increased fatty
acid oxidation in transgenic mice was due to their increased
exercise capacity. However, when the data are expressed as the
percentage of maximal speed, PGC-1a-b transgenic mice still
showed a lower RQ ratio and higher levels of calculated fat
oxidation (Fig. 5D).
These data indicated that PGC-1a-b transgenic mice show
increased fat oxidation and decreased carbohydrate oxidation at
either the absolute exercise intensity, or the same relative exercise
intensities.
Decrease in consumption of carbohydrate as fuel during
exercise in PGC-1a-b transgenic mice
Lipid oxidation was the predominant fuel source for exercise in
PGC-1a-b transgenic mice, whereas consumption of carbohydrate
during exercise was reduced. Glycogen concentration in skeletal
muscles and blood lactate concentration were measured at rest
and 30 min after the exercise tolerance test, a time when the shift
of fuel usage to glucose was manifested. At rest, the glycogen
content in the gastrocnemius in line A and line B PGC-1a-b
transgenic mice was 1.9- and 2.2-fold greater than in wild-type
mice (Fig. 6). At the 30 min mark of the exercise tolerance test,
skeletal muscle glycogen content was decreased to 52% in wild-
type mice but no significant decrease was observed in transgenic
mice. The liver glycogen content was not significantly changed
between rest and 30 min of exercise in either wild-type or
transgenic mice (data not shown). The blood lactate concentration
at 30 min from the start of exercise was increased in wild-type
Figure 4. Skeletal muscle-specific expression of PGC-1a-b induced angiogenesis in skeletal muscle. (A) Transverse frozen sections of TA
from wild-type (Wt) and PGC-1a-b transgenic mice at 10–11 weeks of age were immunostained for CD31 (endothelial-specific PECAM).
Representative immunostains in the superficial region is shown. (B) Quantification of CD31-positive capillaries/mm
2 and capillaries per individual
myofiber in superficial and deep regions (n=3 per group). Data are presented as mean 6 SE. *, P,0.05, ****, P,0.001 vs. Wt.
doi:10.1371/journal.pone.0028290.g004
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(Fig. 6). Furthermore, an increase in blood lactate concentration at
exhaustion was not observed in the transgenic mice (data not
shown), also suggesting that glycogen in skeletal muscle was not
used preferentially during exercise in transgenic mice. The blood
glucose concentration did not differ significantly between the two
groups of mice (data not shown).
Discussion
In this study, we created mice that overexpressed PGC-1a-b in
skeletal muscle but not in heart. PGC-1a-b protein, whose amino
terminus is different from that of PGC-1a-a protein, is a
predominant PGC-1a isoform in skeletal muscles that is expressed
in response to exercise. This is the first in vivo study to examine
exercise capacity in mice overexpressing PGC-1a-b in skeletal
muscle. The alterations in the phenotypes of our transgenic mice
were comparable with those induced by exercise training in mice
and humans. CS activity was increased 3-fold in our transgenic
mice, whereas rats showed a 2-fold increase in mitochondrial
enzymes and in the capacity of skeletal muscle to oxidize pyruvate,
after 12 weeks of treadmill exercise training [43]. The 20%
increase in peak oxygen uptake in transgenic mice was comparable
with the 9–19% increase in VO2max observed after exercise
training in humans [5]. Our data indicated that alterations in
metabolism of skeletal muscles (increased mitochondrial biogen-
esis, angiogenesis, and fatty acid transporter) also contribute to
whole body VO2max and exercise capacity (Fig. 7), in addition to
the contribution of the pump capacity of the heart.
Fat oxidation rates increase from low- to moderate-intensities
and then decrease when the intensity becomes high due to reduced
fatty acid availability and reduced activity of CPT1 [44]. It is also
well known that endurance training can increase fat oxidation
during submaximal exercise [44–49]. Maximal rates of fat
oxidation were shown to be reached at intensities between 59%
and 64% of maximum oxygen consumption in trained individuals
and between 47% and 52% of maximum oxygen consumption in
a large sample of the general population [44]. Increases in fat
oxidation with exercise training were reported when trained and
untrained individuals were compared at the same absolute and
relative exercise intensities [50]. Similar to human athletes, mice
over-expressing PGC-1a-b showed increased fat oxidation at the
same absolute and relative exercise intensities. Increased fat
oxidation during exercise could provide sufficient energy for
muscle contraction and contribute to improved endurance
capacity and exercise performance, as suggested in a previous
study [51].
As for mechanisms of increased fatty acid utilization in skeletal
muscles during exercise in PGC-1a-b transgenic mice, increases in
expression of enzymes for fatty acid b oxidation (MCAD, CPT1
etc.) via activation of PPARa [13], and mitochondrial capacity via
activation of nuclear respiratory factor 1(NRF-1) and NRF-2 [52]
contribute to increased fatty acid oxidation. An increase in fatty
acid transport may also contribute to fatty acid utilization.
Expression of the fatty acid transporter was increased 2 to 5-fold
in skeletal muscle overexpressing PGC-1a-b. It was reported that
the promoter region of CD36 and FATP1 contains a peroxisome
proliferator-responsive element (PPRE) [53,54]. The presence of a
PPRE in the promoter of FABP-pm was not reported, but is likely
as PPARc activation induced the expression of FABP-pm in rat
skeletal muscle [55]. These findings suggest that PGC-1a-b
activates expression of the fatty acid transporter via co-activation
of PPARs. Recently, it was shown that VEGF-B was tightly co-
expressed with nuclear-encoded mitochondrial genes and specif-
ically controlled endothelial uptake of fatty acids via transcrip-
tional regulation of vascular fatty acid transport proteins [35].
Expression of VEGF-B was probably activated via activation of
estrogen-related receptora (ERRa) and its co-activator PGC-1a
Table 3. Substrate utilization is not altered in the sedentary and fasting states in transgenic mice.
Wt PGC-1a-b
Dark cycle VO2 (ml/min/kg
0.75) 19.060.3 19.860.5
VCO2 (ml/min/kg
0.75) 13.760.2 14.460.4
RQ ratio 0.7160.00 0.7260.00
Glucose oxidation (mg/min/kg
0.75) 1.2760.40 1.9560.19
Lipid oxidation (mg/min/kg
0.75)8 . 9 60.2 9.060.2
Energy production (cal/min/kg
0.75) 89.461.3 93.562.3
Total spontaneous physical activity (count) 6487363168 5680766414
Light cycle VO2 (ml/min/kg
0.75) 13.960.4 13.960.2
VCO2 (ml/min/kg
0.75)9 . 9 60.3 10.060.1
RQ ratio 0.7160.00 0.7260.00
Glucose oxidation (mg/min/kg
0.75) 0.3260.28 0.9160.15
Lipid oxidation (mg/min/kg
0.75)6 . 7 60.1 6.560.1
Energy production (cal/min/kg
0.75) 65.161.7 65.360.7
Total spontaneous physical activity (count) 954261741 906961269
Body weight (g) Before fasting 25.060.6 24.460.4
After fasting 21.360.4 20.860.4
Difference during fasting 23.760.2 23.760.1
Oxygen consumption (VO2), carbon dioxide production (VCO2), RQ ratio, spontaneous physical activity, calculated glucose and lipid oxidation rate, and energy
production rate were measured while mice were fasted for 24 hours. Male wild-type (Wt) and PGC-1a-b transgenic mice (line A) at 8 weeks of age. Values are means 6
SE (n=6–8). Significant differences were not observed.
doi:10.1371/journal.pone.0028290.t003
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increase in the expression of VEGF-B might enhance endothelial
uptake of fatty acids. Stimulation of angiogenesis could also
contribute to increased fatty acid oxidation because of the increase
in substrate delivery into the skeletal muscle. PGC-1a-b plays a
role in exercise-induced angiogenesis in skeletal muscle [12]. The
b-AR mediated induction of PGC-1a-b stimulates a broad
program of angiogenic factors, including VEGF, via activation
of ERRa. In fact, skeletal muscle VEGF-A expression and the
number of capillaries were significantly increased in PGC-1a-b
transgenic mice.
Regarding mechanisms of decreased carbohydrate utilization in
skeletal muscles during exercise in PGC-1a-b transgenic mice,
inhibition of glycogenolysis and glycolysis was indicated. There
was no increase in blood lactate concentration in PGC-1a-b
transgenic mice at exhaustion, suggesting that muscle glycogen
usage was absent in the transgenic mice as reported by Wende et
al. [57]. Inhibition of muscle glycogen usage was probably due to a
decrease in expression of genes related to glucose metabolism
following overexpression of PGC-1a-b in the skeletal muscle. The
expression of enzymes for glucose metabolism, such as PHKA1,
PYGM, GLUT4, PFKM, was mediated by one of the NR4A
orphan nuclear receptors, Nur77 [36]. In PGC-1a-b transgenic
mice, reduction of Nur77 mRNA levels in skeletal muscle was
observed concomitantly with a decrease in the expression of genes
linked to glucose metabolism. The mechanism for the decrease in
Nur77 expression in response to overexpression of PGC-1a-b is
unclear at this time. However, because the level of Nur77 mRNA
was lower in soleus muscles (predominantly type 1, slow-twitch,
oxidative fibers) than fast-twitch glycolytic muscles [36], PGC-1a-
b mediated change in the muscle fiber type might be associated
with the decrease in Nur77 expression. Taken together, these data
suggest that PGC-1a-b stimulates fatty acid oxidation and inhibits
carbohydrate oxidation simultaneously via broad actions as a co-
activator of transcription factors.
In the case of PGC-1a-a, another isoform that was studied
extensively [11,33], there were two studies to examine its effects on
exercise performance but their results were inconsistent [16,57].
Initially, Wende et al. reported that conditional induction of PGC-
1a-a in skeletal muscle (not in heart) for 3–4 wk showed increases
in mitochondrial biogenesis, the capacity for mitochondrial fatty
acid oxidation, and muscle glycogen stores [57]. Exercise
performance was not different between control (4.2 km) and
conditional PGC-1a-a mice (3.3 km) under a low-intensity
exercise protocol. However, these conditional PGC-1a-a mice
could not tolerate a high-intensity exercise protocol; control mice
could run 1.7 km and PGC-1a-a mice could run only 0.8 km,
possibly due to the inability to use muscle glycogen during
exercise. In this study, intensities at exhaustion were 80 m/min for
control and 65 m/min for PGC-1a-a mice, suggesting that
conditional over-expression of PGC-1a-a did not have an affect
on endurance performance but reduced performance under
extremely high-intensity exercise. In contrast, Calvo et al. reported
that PGC-1a-a transgenic mice, in which PGC-1a-a expression
was increased both in skeletal muscle and heart constitutively,
showed increased fatty acid oxidation and decreased glycogen
Figure 5. Exercise tolerance, RQ ratio, and calculated glucose and lipid oxidation rate, during exercise. (A) PGC-1a-b transgenic mice
(A-line and B-line, n=3 and 4) and wild-type littermates (Wt, n=7) (each 8 weeks old) were exercised by forced running on a treadmill at 10 m/min.
The speed increased by 2 m/min every 3 min until exhaustion. Mice ran until exhaustion (exercise tolerance test). Exercise tolerance is shown as a
Kaplan-Meier survival curve. A significant difference (P,0.01, log-rank test) was observed between the exercise tolerances of both lines of PGC-1a-b
transgenic mice vs. Wt. (B) Oxygen consumption and carbon dioxide production were monitored using an O2/CO2 metabolism measuring system for
small animals, which was equipped with an air-tight treadmill chamber. The RQ ratio, and calculated glucose and lipid oxidation rates are shown.
Each value is the mean 6 SE of 3–7 mice. Statistical significance was calculated as the area under the curve when sedentary and during running (0–
36 min). Significant differences were not observed when sedentary for any parameters. P values vs. Wt are shown in the figure in cases where the
difference is significant. (C) Peak oxygen uptake as defined by the measurement of oxygen consumption at the point of failure, is shown. *P,0.05 vs.
Wt. (D) The RQ ratio, and calculated glucose and lipid oxidation rate are plotted against relative exercise intensity, as estimated by the percentage of
mean speed at exhaustion for each genotype. Statistical significance was calculated as the area under the curve using the mean value at rest for each
genotype as base line. P values vs. Wt are shown in the figure in cases where the difference is significant.
doi:10.1371/journal.pone.0028290.g005
Figure 6. Skeletal muscle glycogen content and blood lactate concentration before and after exercise. PGC-1a-b transgenic mice and
wild-type littermates (Wt) (each 8 weeks old) were exercised by forced running on a treadmill at 10 m/min. The speed increased 2 m/min every 3 min
up to 30 m/min. Mice ran for 30 min. Skeletal muscle (gastrocnemius) glycogen content was measured before (Sed) and after 30 min of exercise
(n=3–5). Values are means 6 SE. **P,0.01 vs. Sed. {{{P,0.001 vs. Wt. Blood lactate concentration was measured before (Sed) and at 30 min of
exercise (n=4–6). Values are means 6 SE. ***P,0.001 vs. Sed. {{{P,0.001 vs. Wt.
doi:10.1371/journal.pone.0028290.g006
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and peak oxygen uptake [16]. In their study, PGC-1a-a transgenic
mice could run 2.0 km and wild-type mice could run 1.2 km
under a low-intensity exercise protocol (p,0.001). The transgenic
mice could also tolerate more high-intensity exercise than wild-
type mice (p,0.001). Because these two studies used different
exercise protocols, both for the low-intensity (different duration at
initial speed and incline) and high-intensity (intermittent or
continuous protocols) levels, it is difficult to compare the exercise
capacity in mice between these studies. Although we used different
protocols (high-intensity and continuous protocols without an
incline) to determine the exercise capacity, our PGC-1a-b mice
could tolerate a higher intensity of exercise than wild-type mice,
which is similar to the results observed in Calvo’s study for PGC-
1a-a transgenic mice and their higher exercise performance than
wild-type mice.
There are several genetic mouse models that show increased
exercise performance, however their skeletal muscle glycogen
content is variable. Overexpression of constitutive active calci-
neurin in skeletal muscle resulted in increased endurance
performance and mitochondrial function with a higher glycogen
content in skeletal muscles [58]. Mice deficient in actinin-3, in
which expression was restricted largely to the fast glycolytic skeletal
muscles fibers, showed a more efficient aerobic pathway and an
increase in intrinsic endurance performance with a higher
glycogen content [59,60]. However, overexpression of a cytosolic
form of phosphoenolpyruvate carboxykinase in skeletal muscle
also enhanced exercise capacity, and increased in mitochondrial
biogenesis and fatty acid utilization during endurance exercise, but
with a lower glycogen content [61]. This model mouse relied
heavily on fatty acids as a source of muscle energy during exercise
and did not use carbohydrate because no lactate generation was
observed at exhaustion. In contrast, a mouse model with increased
glycolysis and glycogen content in skeletal muscles showed a
decreased running capacity [62]. A conditional transgenic mouse
expressing a constitutively active form of Akt1 showed muscle
hypertrophy due to the growth of type IIb muscle fibers (glycogen
rich fibers), which was accompanied by an increase in strength, but
showed a reduced capacity for running. These studies suggest that
although inhibition of muscle glycogen usage may decrease high
intensity exercise (possibly a model of resistance training) as
observed in the conditional PGC-1a-a induction model, a shift in
the skeletal muscle phenotype to oxidative metabolism and its
increase in lipid utilization during exercise contributes largely to
endurance performance.
In conclusion, a PGC-1a-b-mediated increase in mitochondrial
biogenesis and capillary density in skeletal muscles contributes to
improved exercise capacity. Adaptation to exercise training is
partly due to the induction and activation of PGC-1a-b. Increases
in PGC-1a-b protein or function might be a useful strategy for
sedentary subjects to perform exercise efficiently, and this may aid
in prevention of life-style related diseases and lead to an increased
lifespan.
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